Skip to Main Content

Workshop Will Highlight Cutting-Edge Proteomics Technologies

October 10, 2008
by Office of Public Affairs & Communications

The second in a two-part series of Dean's Workshops focused on the School of Medicine's Keck Biotechnology Resource Laboratory will take place on Friday, Oct. 17, at 1:30 p.m. in The Anlyan Center auditorium, 300 Cedar St.

The workshop, titled "Proteomics — Discovery to Validation: Mass Spectrometry-Based Approaches in Biomedical Research," will highlight the Keck Laboratory's state-of-the-art proteomics technologies for studying a diverse range of disease applications from hypertension to drug addiction, as well as the emergence of new infectious diseases and the effect of bioterror agents.

Featured speakers will be Jesse Rinehart, associate research scientist in the laboratory of Dr. Richard P. Lifton, chair and Sterling Professor of Genetics and a Howard Hughes Medical Institute investigator, who will discuss current proteomics and phosphoproteomic research at the Yale/NHLBI Proteomics Center related to hypertension and sickle-cell disease; Angus C. Nairn, professor of psychiatry and co-principal investigator at the Yale/NIDA Neuroproteomics Center (one of only two such centers in the country), who will discuss proteomics tools used in drug addiction research; and Megan L. Shaw, assistant professor of microbiology at Mount Sinai School of Medicine and a research member of the Northeast Biodefense Center (NBC), who will share her current findings in influenza proteomics in collaboration with the NBC's Proteomics Core at the Keck Laboratory.

Prior to these presentations, there will be a brief overview of currently available proteomic technologies and their applications in biomedical research by Erol Gulcicek, deputy director of the Keck Laboratory's Proteomics Resources and associate research scientist in the Department of Molecular Biophysics and Biochemistry (MB&B), and Christopher M. Colangelo, director of the Keck's Protein Profiling Resource and associate research scientist in MB&B.

The Keck Laboratory strives to bring a wide range of cutting-edge proteomics biotechnologies within reach of hundreds of investigators whose research programs can benefit from the highly sophisticated and expensive instrumentation upon which biological research is increasingly dependent.

The event is free and open to the greater Yale community. At the conclusion of the workshop, attendees will be invited to tour the Keck Proteomics facilities located at 300 George St. Refreshments will be served.

The work above was funded, fully or in part, by the Yale Clinical and Translational Science Award (CTSA) grant from the National Center for Research Resources at the National Institutes of Health.

Contact

Office of Public Affairs & Communications
203-432-1345

Click here to view the original article.